Kiesel L

No ORCID on file · 54 papers in corpus
rct 1996
Should add-back therapy for endometriosis be deferred for optimal results?
British journal of obstetrics and gynaecology

Add-back hormone replacement therapy has been shown to alleviate some of the hypo-oestrogenic side effects associated with gonadotrophin-releasing hormone agonists, including demineralisation of bone. Studies on patients with uterine fibroi…

review 1990
Mechanisms involved in the hormonal treatment of endometriosis
Progress in clinical and biological research
other 1989
Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-68-6-1167

We studied the pharmacokinetics of iv and intranasally administered buserelin, a LHRH agonist peptide, in 14 women with endometriosis. Serum and urinary buserelin concentrations were determined by specific RIA (buserelin antiserum AS-639). …

rct 1989
[Treatment of endometriosis]
Archives of gynecology and obstetrics ·doi:10.1007/bf02417628

In a randomized study, the effect of gestrinone (2 x 2.5 mg/week) was compared with the effect of danazol (3 x 200 mg/day) in treating 30 patients with laparoscopically proven endometriotic implants for 6 months. Therapy was effective in 80…